Predicting Urothelial Cancer Recurrence with MMP-2 and TIMP-2 Levels
Author Information
Author(s): K Gohji, N Fujimoto, J Ohkawa, A Fujii, M Nakajima
Primary Institution: Hyogo Medical Center for Adults
Hypothesis
The serum MMP-2/TIMP-2 ratio can predict the recurrence of urothelial cancer.
Conclusion
An imbalance between serum MMP-2 and TIMP-2 levels is a significant predictor of recurrence in advanced urothelial cancer patients.
Supporting Evidence
- The serum MMP-2/TIMP-2 ratio was significantly higher in patients with recurrence compared to those without.
- Patients with high MMP-2/TIMP-2 ratios had poorer disease-free survival rates.
- Univariate and multivariate analyses showed the MMP-2/TIMP-2 ratio as a significant independent predictor of recurrence.
Takeaway
Doctors can check the levels of certain proteins in the blood to see if a bladder cancer patient might have their cancer come back after treatment.
Methodology
Serum levels of MMP-2 and TIMP-2 were measured in 97 urothelial cancer patients and compared to 127 healthy controls.
Limitations
The study only included patients who underwent complete resection and may not apply to all urothelial cancer patients.
Participant Demographics
97 urothelial cancer patients (44 superficial, 53 advanced) and 127 healthy controls (85 males, 42 females, ages 18-69).
Statistical Information
P-Value
P = 0.0029
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website